Structure-activity relationships and optimization of acyclic acylphloroglucinol analogues as novel antimicrobial agents
Structure-activity relationships and optimization of acyclic acylphloroglucinol analogues as novel antimicrobial agents
复制标题
无环酰基间苯三酚类似物作为新型抗菌剂的构效关系及优化
DOI:
10.1016/j.ejmech.2016.09.054
复制
发表时间:
2017
影响因子:
6.7
通讯作者:
Qiu Shengxiang
中科院分区:
文献类型:
--
作者:
Tan Haibo;Liu Hongxin;Zhao Liyun;Yuan Yao;Li Bailin;Jiang Yueming;Gong Liang;Qiu Shengxiang
Methicillin-resistantStaphylococcus aureus(MRSA) poses a serious threat to global public health, because it exhibits resistance to existing antibiotics and therefore high rates of morbidity and mortality. In this study, twenty-one natural product-based acylphloroglucinol congeners were synthesized, which possessed different side chains. Antibacterial screening against MRSA strains revealed that acyl moiety tailoring is a prerequisite for the antibacterial activity. Moreover, the lipophilicity, rather than the magnitude of the hydrophobic acyl tail dominates variability in activity potency. Compound11jwas identified as a promising lead for the generation of new anti-MRSA drug development. It was discovered by optimization of the side chain length in light of the potency, the breadth of the antibacterial spectrum, the rate of bactericidal action, as well as the membrane selectivity. Compound11jexerted profoundin vitroantibacterial activity against the MRSA strain (JCSC 2172), and its MIC was 3-4 orders of magnitude lower than that of vancomycin. A preliminary mode of action study of compound11jat the biophysical and morphology levels disclosed that the mechanism underlying its anti-MRSA activity included membrane depolarization and, to a lesser extent, membrane disruption and cell lysis.